Unknown PHASE4 INTERVENTIONAL 2-arm NCT06242041

The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis Patients (ART Study)

The Effect of Potassium Lowering Drugs on Cardiac Electrical Stability in Hemodialysis

Sponsor: Peking University First Hospital

Conditions Cardiac Arrhythmia Dialysis; Complications Potassium Imbalance

Interventions sodium zirconium cyclic silicate

Updated 4 times since 2024 Last updated: Jan 28, 2024 Started: Feb 14, 2022 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cardiac Arrhythmia and Dialysis; Complications, this trial is ongoing. The trial is conducted by Peking University First Hospital and has accumulated 4 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Mar 2024 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University First Hospital

Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China